Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory J Dore

Showing results (61-70 of 466) with videos related to

Pageof 47
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2013
Moving the agenda forward: the prevention and management of hepatitis C virus infection among people who inject drugsJason Grebely, Philip Bruggmann, Markus Backmund, et al.
Australian and New Zealand Journal of Public Health|January 16, 2004
Blood-borne viruses and their survival in the environment: is public concern about community needlestick exposures justified?Sandra C Thompson, Clem R Boughton, Gregory J Dore
Lancet (London, England)|October 18, 2002
Immunity against hepatitis C virus infectionGregory J Dore, Anthony J Freeman, John M Kaldor
Drug and Alcohol Dependence|August 13, 2013
Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, AustraliaCarla Treloar, Jake Rance, Jason Grebely, et al.
Australian and New Zealand Journal of Public Health|February 15, 2005
Hepatitis C virus incidence among injecting drug users on opioid replacement therapyRichard Hallinan, Andrew Byrne, Janaki Amin, et al.
Nature Medicine|February 13, 2020
Global elimination of hepatitis C virus by 2030: why not?Gregory J Dore, Marianne Martinello, Maryam Alavi, et al.
Antiviral Therapy|May 17, 2007
Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovirGail V Matthews, David A Cooper, Gregory J Dore
Journal of Hepatology|October 13, 2017
Reply to: "Direct antiviral agents and risk of HCC: Waiting for Godot"Reem Waziry, Janaki Amin, Matthew Law, et al.
Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology|March 7, 2018
Determinants of survival following hepatocellular carcinoma in Egyptian patients with untreated chronic HCV infection in the pre-DAA eraReem Waziry, Asmaa Gomaa, Imam Waked, et al.
Herpes : the Journal of the IHMF|February 28, 2002
Human Herpesvirus 8 and Protection from AIDS Dementia ComplexAndrew E Grulich, Gregory J Dore, Bruce J Brew
Pageof 47

Showing results (61-70 of 466) with videos related to

Sort By:
Pageof 47
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2013
Moving the agenda forward: the prevention and management of hepatitis C virus infection among people who inject drugsJason Grebely, Philip Bruggmann, Markus Backmund, et al.
Australian and New Zealand Journal of Public Health|January 16, 2004
Blood-borne viruses and their survival in the environment: is public concern about community needlestick exposures justified?Sandra C Thompson, Clem R Boughton, Gregory J Dore
Lancet (London, England)|October 18, 2002
Immunity against hepatitis C virus infectionGregory J Dore, Anthony J Freeman, John M Kaldor
Drug and Alcohol Dependence|August 13, 2013
Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, AustraliaCarla Treloar, Jake Rance, Jason Grebely, et al.
Australian and New Zealand Journal of Public Health|February 15, 2005
Hepatitis C virus incidence among injecting drug users on opioid replacement therapyRichard Hallinan, Andrew Byrne, Janaki Amin, et al.
Nature Medicine|February 13, 2020
Global elimination of hepatitis C virus by 2030: why not?Gregory J Dore, Marianne Martinello, Maryam Alavi, et al.
Antiviral Therapy|May 17, 2007
Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovirGail V Matthews, David A Cooper, Gregory J Dore
Journal of Hepatology|October 13, 2017
Reply to: "Direct antiviral agents and risk of HCC: Waiting for Godot"Reem Waziry, Janaki Amin, Matthew Law, et al.
Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology|March 7, 2018
Determinants of survival following hepatocellular carcinoma in Egyptian patients with untreated chronic HCV infection in the pre-DAA eraReem Waziry, Asmaa Gomaa, Imam Waked, et al.
Herpes : the Journal of the IHMF|February 28, 2002
Human Herpesvirus 8 and Protection from AIDS Dementia ComplexAndrew E Grulich, Gregory J Dore, Bruce J Brew
Pageof 47